๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Metabolism of tritiated angiotensin II in anaesthetized rats

โœ Scribed by Mary J. Osborne; Nicole Pooters; Ghislaine Angles d'Auriac; Alan N. Epstein; Manuel Worcel; Philippe Meyer

Publisher
Springer
Year
1971
Tongue
English
Weight
795 KB
Volume
326
Category
Article
ISSN
0031-6768

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The metabolism of tritiated thioacetamid
The metabolism of tritiated thioacetamide in the rat
โœ K. R. Rees; G. F. Rowland; J. S. Varcoe ๐Ÿ“‚ Article ๐Ÿ“… 1966 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 700 KB

A method is described for preparing tritiated thioacetamide. Thi~acetamide-~H was fed daily to rats at a level which is known to produce liver tumours after six months' feeding. It was shown that less than I % was excreted

Effects of the administration of angiote
Effects of the administration of angiotensin II on cardiac glycogen metabolism in the rat
โœ V. Tata; A. Roso; Z. Gori; E. Bergamini ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer ๐ŸŒ English โš– 677 KB

Changes in glycogen metabolism after an intravenous injection of angiotensin II were investigated in the left and right ventricles of the rat heart, as a function of location within the ventricular wall. Hearts were cut into 100-Arm thin sections, all of which were analysed for glycogen content, glu

Radiation stability of angiotensin II-am
Radiation stability of angiotensin II-amide and of its tritiated derivatives
โœ J. Kopoldovรก; ล . Hrnฤรญล™; I. Mezรถ ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 376 KB

## Abstract The gammaโ€radiolysis of aqueous solutions of the peptide hormone angiotensin IIโ€amide and the betaโ€autoradiolysis of its tritiated preparations were studied. The radiation loss and the decrease of biological activity of angiotensin IIโ€amide was evaluated. The main fractions of radiation

The pharmacokinetics and metabolism of C
The pharmacokinetics and metabolism of CP-191,166, an angiotensin II receptor antagonist, in rats and dogs
โœ Mary C. Allen; Mark R. Nocerini; Wesley W. Day ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 177 KB ๐Ÿ‘ 1 views

166 is an orally active, non-peptide angiotensin II (AII) receptor antagonist developed for the treatment of hypertension and congestive heart failure (CHF). In this study, the intravenous (iv) and oral (po) single dose pharmacokinetics (PK), oral multiple dose PK and P450-mediated metabolism of 16